Pomalidomide-PEG2-butyl iodide
≥95%
- Product Code: 98725
CAS:
1835705-72-0
| Molecular Weight: | 585.39 g./mol | Molecular Formula: | C₂₃H₂₈IN₃O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, sealed, dry |
Product Description:
Used primarily in the development of targeted cancer therapies, this compound is designed to enhance drug delivery systems. It is particularly valuable in the modification of small molecules to improve their solubility and bioavailability, which is crucial for effective treatment. The inclusion of PEG (polyethylene glycol) helps in reducing immunogenicity and increasing circulation time in the body, making it a critical component in the formulation of more efficient therapeutic agents. This chemical is often utilized in research settings to study and optimize the pharmacokinetics of drug candidates, especially in the context of treating multiple myeloma and other cancers. Its role in the synthesis of antibody-drug conjugates (ADCs) is also noteworthy, as it aids in the precise targeting of cancer cells while minimizing damage to healthy tissues.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿6,318.00 |
+
-
|
Pomalidomide-PEG2-butyl iodide
Used primarily in the development of targeted cancer therapies, this compound is designed to enhance drug delivery systems. It is particularly valuable in the modification of small molecules to improve their solubility and bioavailability, which is crucial for effective treatment. The inclusion of PEG (polyethylene glycol) helps in reducing immunogenicity and increasing circulation time in the body, making it a critical component in the formulation of more efficient therapeutic agents. This chemical is often utilized in research settings to study and optimize the pharmacokinetics of drug candidates, especially in the context of treating multiple myeloma and other cancers. Its role in the synthesis of antibody-drug conjugates (ADCs) is also noteworthy, as it aids in the precise targeting of cancer cells while minimizing damage to healthy tissues.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :